FEXORA NEWS • SCIENCE DESK
Science & Health
Evidence-led reporting on medical research, public health, medicines, biotechnology, neuroscience and the scientific ideas shaping everyday life. We explain what new findings mean, what remains uncertain and how discoveries may translate into real-world care.
The latest in science and global health
Our coverage follows research and policy developments from universities, peer-reviewed journals, public-health agencies, regulators and healthcare systems. We distinguish early laboratory findings from clinical evidence, regulatory decisions and established medical guidance.
WHO launches a global movement to strengthen trust in science
On 10 November 2026, the World Health Organization announced Together for Science and Health, a movement bringing more than 240 organisations together to improve public trust in scientific evidence. Its priorities include closer collaboration between science and society, stronger evidence-informed policy and clearer communication that can counter misinformation.
Ebola vaccine research advances through new trial candidates
On 4 November 2026, WHO reported that two additional candidate vaccines had been recommended for inclusion in the ongoing Tumaini clinical trial in the Democratic Republic of the Congo. These are investigational candidates: trial participation and further evaluation are necessary before conclusions can be drawn about effectiveness or routine use.
See WHO’s latest news releases
New research examines how the blood–brain barrier transports proteins
Research reported on 13 November 2026 describes how selected proteins in the bloodstream may cross the blood–brain barrier and reach specific brain cells. The findings include animal-model evidence involving APOA1 and neuronal connections. The work may help researchers investigate future approaches to neurological disease, but it is not an established Alzheimer’s treatment and requires further validation in people.
What we cover
Medicine & therapeutics
Drug discovery, clinical trials, medicines regulation, pharmacology, antimicrobial resistance, treatment access and medication safety.
Public health
Infectious diseases, vaccination, health systems, prevention, epidemiology, maternal and child health and health policy.
Science & technology
Biotechnology, genetics, neuroscience, medical devices, diagnostics, artificial intelligence and research innovation.
Our editorial standards
We identify the source and date of significant claims, explain the strength and limitations of evidence, and avoid presenting preliminary findings as proven treatments. Health coverage is for public information and does not replace individual medical advice. Corrections and material updates should be clearly identified.
Latest science, health and technology stories
-
Binance Targets Full Withdrawal Restoration After $6.3bn Security Breach
Binance says withdrawals have reopened across 87 networks and it aims to restore remaining services by the end of next week after a reported $6.3bn theft.
-
SpaceX’s Starship Upper Stage Completes First Tower Catch in Reusability Milestone
SpaceX caught Starship’s upper stage with its launch tower for the first time, although the booster was not recovered and exploded over the Gulf of Mexico.
-
Microsoft 365 Outage Exposes the Risks of Cloud-Service Concentration
A disruption to Microsoft 365 highlights the systemic risks created when organisations rely on a small number of cloud platforms for essential digital services.
-
Extended Microsoft 365 Disruption Tests Business Continuity Worldwide
A prolonged Microsoft 365 outage disrupted communications and collaboration across multiple regions, testing organisations’ contingency plans and operational resilience.
-
APEC 2026: Trade, Technology and Geopolitics Set to Shape Shenzhen Summit
Leaders gathering in Shenzhen on 18–19 November face a consequential agenda spanning trade tensions, artificial intelligence, critical minerals and regional security.
-
US Disrupts North Korean Crypto Theft Network After $400 Million FaceStealer Scheme
The US Justice Department says it seized infrastructure linked to a North Korean social-engineering operation blamed for more than $400 million in cryptocurrency theft over 18 months.
-
Europe’s AI Ambitions Take Centre Stage at Dublin Summit
European leaders are using a first dedicated AI summit in Dublin to confront the region’s competitiveness gap, funding challenges and questions around AI safety and regulation.
-
Chinese AI Server Maker xFusion Clears Key Review for Planned $1.2 Billion IPO
xFusion Digital Technologies has cleared a key Shenzhen listing review for a proposed 8 billion yuan offering, although the exchange raised questions about margins and business sustainability.
-
Taiwan’s AI Chip Boom Raises the Stakes for Investors and the Wider Economy
Taiwan’s semiconductor leadership is driving market gains and global strategic importance, while raising questions about concentration risk, household exposure and who benefits from the AI boom.
-
SpaceX and Tesla Merger Talks Put Musk’s Business Empire in Focus
Reports that SpaceX and Tesla are advancing merger discussions have revived questions about scale, governance, regulation and the future of an unusually broad technology empire.